INCA035784
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for INCA035784, covering 2026-04-06 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms [Phase 1]